心力健丸联合常规西药治疗慢性心力衰竭临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.6

基金项目:

2016年度武汉市临床医学(中医药及中西医结合类)科研项目(WZ16D09)


Clinical Study on Xinlijian Pills Combined with Routine Western Medicine for Chronic Heart Failure
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察心力健丸联合常规西药治疗慢性心力衰竭的疗效。方法:将 60 例心肺气虚、血瘀水停型慢性心力衰竭患者随机分为对照组和治疗组各 30 例。2 组均给予利尿、扩张血管、增强心肌收缩力等常规西药治疗,治疗组加服心力健丸,2 组均连续治疗 9 d。治疗前后评定 2 组患者的中医证候积分、Lee 氏心力衰竭积分、心功能分级,检测 N-末端 B 型利钠肽原(NT-proBNP),比较 2 组的临床疗效。结果:治疗后,治疗组改善中医证候、心力衰竭及心功能的疗效均优于对照组(P<0.01, P<0.05)。2 组中医证候积分、Lee 氏心力衰竭积分、NT-proBNP 值均较治疗前下降,差异均有统计学意义 (P<0.05),治疗组各指标值均低于对照组(P<0.05)。结论:常规西药联合心力健丸治疗心肺气虚、血瘀水停型慢性心力衰竭患者,在改善其心力衰竭症状、提高心功能方面的效果优于单纯使用西药治疗。

    Abstract:

    Abstract:Objective:To observe the curative effect of Xinlijian pills combined with routine western medicine for chronic heart failure. Methods:A total of 60 cases of patients with chronic heart failure of heart-lung qi deficiency and blood stasis and water retention type were randomly divided into the control group and the treatment group,30 cases in each group. Both groups were given routine western medicine for diuresis,dilating vessels and strengthening myocardial contractility,and the treatment group was additionally treated with Xinlijian pills. Both groups were treated for nine days. Before and after treatment,Chinese medicine syndrome scores and Lee's heart failure scores,heart function classification in the two groups were evaluated,and N- terminal pro b- type natriuretic peptide(NT- proBNP) was detected. The clinical effect in the two groups was compared. Results:After treatment,the curative effect of Chinese medicine syndromes,heart failure and heart function improvement in the treatment group was better than that in the control group(P<0.01,P<0.05),and the scores of Chinese medicine syndromes and Lee's heart failure scores as well as NT-proBNP values in the two groups were decreased when compared with those before treatment,differences being significant(P<0.05),and the indexes in the treatment group were all lower than those in the control group(P<0.05). Conclusion: Based on routine western medicine, the additional therapy of Xinlijian pills for CHF patients of heart-lung qi deficiency and blood stasis and water retention type has better effect than that of simple western medicine in improving symptoms of heart failure and heart function.

    参考文献
    相似文献
    引证文献
引用本文

陈朝金,刘小娣,张思,孙雪平,陈逊,夏贤龙,吴敏.心力健丸联合常规西药治疗慢性心力衰竭临床研究[J].新中医,2020,52(24):50-53

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-12-22
  • 出版日期: